ArticleNeurochemical research2025
CAD (Cath. a-Differentiated) Cells Produce Dopamine along with Dopamine-Synthesizing Enzymes.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuron-specific modulation of SLC30A10 identifies dopaminergic and glutamatergic neurons as targets of manganese-induced motor disease.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Proteomic profiling reveals mitochondrial metabolic alterations in dexamethasone-induced neuronal differentiation.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Brain dopaminergic (DAergic) neurons play a critical role in mediating motor, reward, and cognitive processes, but are particularly vulnerable to toxic insults associated with Parkinson's disease and manganism. Several cell lines have been used to study DAergic function and toxicity, and each has distinct advantages and limitations. Here, we investigated whether cath. a-differentiated (CAD) cells, a mouse-derived catecholaminergic cell line, are suitable for DAergic neurotoxicity research as an in vitro model, focusing on their ability to synthesize dopamine (DA) and the expression of key associated proteins. Manganese (Mn) was also tested to determine its DAergic toxicity potential. CAD cells were differentiated with serum deprivation. High-performance liquid chromatography, western blotting, and RT-qPCR were used to assess DA levels, and the expressions of DAergic proteins such as tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AAAD), vesicular monoamine transporter-2 (VMAT-2), and DA transporter (DAT). The results showed that differentiated CAD cells had higher DA levels compared to undifferentiated cells. L-3,4-dihydroxyphenylalanine (L-DOPA), the DA precursor, increased DA production, while carbidopa, an AAAD inhibitor, decreased its production. CAD cells also expressed AAAD protein, indicating that the latter participates in DA synthesis in this cell line. Moreover, Mn decreased DA as well as mRNA and protein levels of DA synthesizing enzymes, such as TH and AAAD, and VMAT-2, thus impairing the DAergic system. Taken together, differentiated CAD cells possess the capability to synthesize DA and express DA-synthesizing enzymes. In addition, Mn caused DAergic toxicity in CAD cells, suggesting that CAD cells are suitable for studying DAergic neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.